T. S. Eugene Ng is a Professor of Computer Science and Electrical & Computer Engineering at Rice University. He holds appointments in both departments and chairs the CS Grad Committee. His research focuses on network architectures, optical networking, and machine learning applications in distributed systems. Education: B.S. in Computer Engineering (with distinction and magna cum laude), University of Washington M.S. and Ph.D. in Computer Science, Carnegie Mellon University Research Interests: Developing robust network infrastructure, optical circuit-switched systems, congestion control, and efficient machine learning frameworks. Current projects include BOLD (Big data and Optical Lightpaths Driven) networking, telemetry systems like Söze, and gradient compression techniques for distributed training. Awards: IEEE Fellow (2023) Alfred P. Sloan Research Fellow (2009) National Science Foundation CAREER Award (2005) IBM Faculty Award (2009) Kavli Fellow Professional Activities: Chair of the 2018 ACM SIGCOMM Distinguished Dissertation Award Committee, Associate Editor for IEEE Transactions on Big Data, and organizer of multiple networking conferences/workshops. Active in program committees for SIGCOMM, NSDI, and CoNEXT. Teaching: Courses include Introduction to Computer Networks, Advanced Computer Networks, and seminars in distributed computing and network systems.
Matthew B. Blaschko is a Professor in the Department of Electrical Engineering at KU Leuven, Belgium. He serves as director of the KU Leuven ELLIS unit and is a fellow in the ELLIS Health program. He is a Core PI in the Flanders AI Research Program, working as a workpackage lead for Decision Support Systems and Medical Imaging. Blaschko is also a member of the KU Leuven Institute for Artificial Intelligence and one of the leaders of the working group on Machine Learning and Data Science. Professor Blaschko received his B.S. from Columbia University, M.S. from the University of Massachusetts Amherst, and Dr. rer. nat. from Technische Universität Berlin (awarded for work at Max Planck Institutes Tübingen). He was a Newton International Fellow at the University of Oxford and received his Habilitation (HDR) from École Normale Supérieure de Cachan. Prior to joining KU Leuven, he was a Permanent Research Scientist in the INRIA Saclay Research Center and a Faculty Member at Ecole Centrale Paris. His research focuses on machine learning techniques applied to visual data, with particular emphasis on calibration in deep learning, medical image analysis, and federated learning. Blaschko's work bridges theoretical foundations with practical applications, as evidenced by technology developed in his research being incorporated into MONA, software for ophthalmic image analysis. His research group has made significant contributions to the fields of model calibration, uncertainty estimation, and medical imaging analysis, with recent publications showing strong trends toward improving reliability of AI systems in medical contexts and advancing theoretical understanding of calibration metrics. Professor Blaschko has been recognized with several awards including the Université Paris-Saclay STIC Doctoral School Best Scientific Contribution Award, Best Paper Award at CVPR 2008, Main Award at DAGM 2008, and Best Student Paper Award at ECCV 2008. Professor Blaschko has supervised numerous PhD and Master's students, with current and former students including Deniz Soysal, Claire Marchal, Dongli Xu, Sebastian Gruber, Jiameng Li, Marco Mezzina, and many others working on diverse topics from Alzheimer's disease analysis to surgical phase recognition. His research has been supported by various funding sources including the Flanders AI Research Program. He has co-organized several influential workshops including the "Another Brick in the AI Wall: Building Practical Solutions from Theoretical Foundations" at CVPR 2025, Commands 4 Autonomous Vehicles workshop at ECCV 2020, and the Learning from Limited Labeled Data workshop series at NIPS 2017 and ICLR 2019. His laboratory focuses on machine learning for medical image analysis, with applications in ophthalmology, neurology, and surgical robotics. The group maintains active collaborations with medical institutions and participates in international challenges such as the KNee OsteoArthritis Prediction (KNOAP2020) challenge.
Jessica Williams, PhD is an Assistant Professor in the Department of Neurosciences at the Cleveland Clinic Lerner Research Institute (LRI) with additional faculty appointments at Case Western Reserve University, Kent State University, and Cleveland State University. She serves as the Cleveland Clinic liaison for Kent State University and represents the Clinic on the Executive Council for the Brain Health Institute and the Biomedical Sciences Graduate Program Executive Committee. Education: Postdoctoral Fellowship in Neuroimmunology, Washington University School of Medicine (2017) Ph.D. in Immunology, The Ohio State University (2011) M.S. in Physiology, Purdue University (2006) B.S. in Biology/Chemistry, Lindenwood University (2004) Dr. Williams' research focuses on neuroimmune interactions during multiple sclerosis, particularly examining regional responses of CNS glia to immune stimuli and astrocyte-immune crosstalk. Her lab employs murine MS models, primary human and murine cell analyses, and MS patient lesion assessment to investigate cytokine-mediated neuroprotection and CNS repair mechanisms. Recent work highlights protective astrocyte functions mediated by traditionally deleterious cytokines. Analysis of her 15 most recent publications reveals consistent focus on neuroimmune crosstalk in MS, with increasing emphasis on astrocyte heterogeneity, cytokine signaling (particularly IFNγ), and novel therapeutic targets like immunoproteasomes. Key themes include regional CNS differences in immune responses, glial cell repair mechanisms, and translating basic findings into potential MS therapies. Scientific Awards: Lerner Research Institute Excellence in Education Award (2022) Mentor of the Year Award (2023) Dr. Williams actively mentors the next generation of scientists as evidenced by her CIMER Trained Mentor certification and the graduation of PhD student Brandon Smith. Her research is supported by significant funding from the NIH, National MS Society, W.M. Keck Foundation, Brain Health Research Institute, and Neurological and Vision Impact Area. She regularly serves on study sections for the NIH, National MS Society, and Department of Defense. The Williams Laboratory investigates the interplay between immune and central nervous systems during MS, with current projects examining cytokine-mediated neuroimmune crosstalk for CNS repair and regionally distinct glial responses to inflammation. The lab employs advanced techniques including murine MS models and primary human cell analyses to identify novel therapeutic pathways for MS patients.
Konstantinos Anastassiadis is a Professor at the Center for Molecular and Cellular Bioengineering (CMCB) of Dresden University of Technology , leading the Stem Cell Engineering group at the Biotechnology Center (BIOTEC) . His research focuses on unraveling molecular pathways regulating stem cell self-renewal and lineage commitment, with a strong emphasis on genetic engineering tool development and epigenetic mechanisms during cellular reprogramming. The lab utilizes mouse and human embryonic stem cells, neural stem cells, mesenchymal stromal cells, and induced pluripotent stem cells (iPSCs) in their investigations. Core Research Areas: Molecular regulation of stem cell fate Epigenetic mechanisms (e.g., UTX/UTY histone demethylases) Genetic engineering tool development (Flp, Dre, Vika recombinases, CRISPR protocols) Conditional immortalization systems for rare cell expansion Publications highlight his contributions to understanding: Role of histone methyltransferases (MLL1, MLL2, Setd1b) in hematopoiesis and cancer Epigenetic regulation during mouse development and spermatogenesis Genetic tools for protein tagging, transposon-mediated BAC transgenesis Interactions between stem cells and niche microenvironments Transcriptional and mechanical markers during reprogramming Collaborations span immunology , developmental biology , and bioinformatics . The lab actively participates in teaching activities at CMCB and maintains a focus on translational applications of stem cell research.
Kenneth Hoehn is an Assistant Professor in the Department of Biomedical Data Science at the Geisel School of Medicine, Dartmouth College. As a computational immunologist with expertise in evolutionary biology, he develops computational evolutionary approaches to trace cellular lineages, particularly B cells, in contexts such as infection, vaccination, cancer, and autoimmune diseases. His research focuses on understanding adaptive immunity in conditions like COVID-19 Food allergies Myasthenia gravis through collaborations with experimental teams. Key projects include: Phylogenetic modeling of B cell responses Evolutionary signatures in immune repertoires Tracking B cell dissemination in autoimmune diseases Epigenetic regulation of memory B cells Recent publications highlight trends in single-cell immunology , phylogenetic inference , and computational tools for analyzing B cell dynamics. His lab at Dartmouth integrates evolutionary genetics with high-resolution immune profiling.
Silvia Santos is a Group Leader at the Francis Crick Institute, leading the Quantitative Stem Cell Biology Lab since January 2018. Her research focuses on understanding cell decision-making during transitions, specifically cell division and differentiation in early development using human embryonic stem cells. She combines experimental techniques with theoretical approaches, including advanced microscopy, genomics, and computational modeling. Education and Career: PhD in Molecular and Cell Biology from EMBL-Heidelberg (2008), followed by postdoctoral training at Stanford University (2009-2014). She held an MRC Career Development Award at Imperial College London (2014-2017) before joining the Crick. Her work emphasizes interdisciplinary methods to study cellular processes in health and disease. Research Interests: Spatial-temporal control in cell decisions, stem cell differentiation, cell cycle regulation, and modeling embryonic development. She advocates for women in science and mentorship programs for early-career researchers. Key Achievements: Recipient of Marie Curie E-Star, EMBO, and HFSP fellowships. Recognized with the BioModels’ Model of the Year 2023 for contributions to systems biology. Her lab develops models like gastruloids to study embryonic development. Grants and Mentorship: Supported by MRC and other grants. Committed to fostering excellence in training and mentorship, previously chairing mentorship initiatives at Imperial College London. Labs and Teams: Quantitative Stem Cell Biology Lab at the Crick, collaborating with interdisciplinary teams on projects involving proteomics, genomics, and high-throughput screening.
Qiang Tang is currently an Associate Professor (Level D) at the School of Computer Science of The University of Sydney. Previously, he was a Senior Lecturer (2021.1-2024.12) at USYD and an Assistant Professor at the Computer Science Department of New Jersey Institute of Technology (2016.8-2021.1), where he co-directed the JACOBI Blockchain Lab with Prof. Jian Pei and Prof. Zhenfeng Zhang. He completed his PhD at the University of Connecticut under Prof. Aggelos Kiayias and Prof. Alexander Russell, following postdoctoral research at Cornell University with Prof. Elaine Shi. His research spans applied and theoretical cryptography, blockchain technology, privacy, and computer security. His work is supported by ARC, Google, Ethereum Foundation, Stellar Foundation, Protocol Labs, Algorand Foundation, Oracle, and USYD. Previous funding includes NSF, JD.com, AFRL, DoE, and Particl Foundation. His research has led to significant contributions in consensus protocols, distributed randomness generation, secure multi-party computation, and privacy-preserving technologies. Tang's publications reveal a strong focus on practical cryptographic solutions for blockchain and distributed systems. His recent work demonstrates expertise in asynchronous consensus, optimal protocol design, and secure implementations for real-world applications. His research shows consistent innovation in improving efficiency, security, and scalability of distributed systems. Scientific Awards: 2025 DSN Best Paper Award 2024 ICDCS Distinguished Paper Award 2023 SOAR Prize, USYD 2023 Oracle for Research Award 2022 Stellar Foundation Research Awards 2022 Ethereum Academic Award 2019 MIT Technical Review, 35 Chinese Innovators Under 35 Tang actively mentors PhD and Master's students, with several alumni now holding faculty positions or research roles at institutions like City University Hong Kong, Chinese Academy of Sciences, and A*STAR Singapore. He has received significant research funding including a multi-year Google project on End-to-End Secure Cloud and an ARC DP grant on Order Fairness in Decentralized Systems. He leads the research in his lab focusing on blockchain protocols and cryptographic applications, with strong industry connections through collaborations with Google, Ethereum Foundation, Stellar Foundation, and Protocol Labs. His team regularly publishes in top security and cryptography venues including CRYPTO, CCS, USENIX Security, and S&P.
Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.
Li Tang is an Associate Professor with tenure at École polytechnique fédérale de Lausanne (EPFL), affiliated with the Institute of Bioengineering (IBI) and the Institute of Materials Science and Engineering (IMX) within the School of Engineering (STI). She leads the Laboratory of Biomaterials for Immunoengineering, focusing on developing innovative strategies at the intersection of immunology, materials science, and cancer therapy. Her work bridges fundamental research and clinical translation, with multiple ongoing clinical trials based on CAR-T cell therapies developed in her lab. B.S. in Chemistry, Peking University (2003–2007) Ph.D. in Materials Science and Engineering, University of Illinois at Urbana-Champaign (2007–2012) Postdoctoral Fellow, MIT (2013–2016) Her research lies at the forefront of immunoengineering, integrating chemical, metabolic, and mechanical approaches to modulate immune responses. Key areas include cancer immunotherapy, immune metabolism, mechano-immunology, and biomaterials. She investigates how physical and biochemical cues can reprogram T cells, overcome exhaustion, and enhance tumor targeting. Her work emphasizes multidimensional immunity-disease interactions, aiming to develop safer and more effective therapies for cancer and autoimmune diseases. The recent publications highlight a strong trend in engineering immune cells (especially CAR-T) for enhanced durability and function, using advanced biomaterials and metabolic reprogramming. There is a clear focus on overcoming challenges in solid tumors, modulating the tumor microenvironment, and translating findings into clinical applications. The use of nanoparticle delivery, single-cell analysis, and biomechanical cues are recurring themes across her work. Notable scientific awards include: Friedrich Miescher Award (2025) ERC Starting Grant (2018) MIT TR35 Innovators Under 35 (China Region, 2020) Nano Research Young Innovator Award (2018) Biomaterials Science Emerging Investigator (2019) Materials Horizons Emerging Investigator (2020) Li Tang actively mentors PhD students across multiple doctoral programs (EDBB, EDMS, EDMX) and has advised numerous graduates who have gone on to prestigious postdoctoral and faculty positions. She is involved in significant research grants, including an Innosuisse project with Novochizol SA, and her lab is supported by competitive funding. She teaches core courses such as Immunoengineering and Next-Generation Biomaterials, shaping the next generation of scientists. Her lab fosters interdisciplinary collaboration and innovation, with active projects in chemical, metabolic, and mechanical immunoengineering, as well as CAR-T cell development. She is the Principal Investigator of the Tang Lab, which includes postdoctoral fellows, PhD students, and technical staff. The lab is actively recruiting and has a strong publication and clinical translation record. Tang Lab is also involved in multiple MA/BA training projects and promotes student engagement in cutting-edge research. The lab’s discoveries are being translated into clinical trials, reflecting a strong commitment to translational science.
Jo Wood is Professor of Visual Analytics in the Department of Computer Science at City, University of London, where she has been employed since January 14, 2000. Her work bridges computer science, geographic information science, and human-computer interaction, focusing on innovative methods for visualizing complex spatial and behavioral data. Her research interests center on visual analytics , information visualization , and geovisualization , with applications in transportation, public health, crisis response, and citizen science. She investigates how interactive visual interfaces can support exploratory data analysis, decision-making, and storytelling, particularly through small multiples, faceted views, and sketch-based rendering techniques. The trends in her recent publications reflect a consistent focus on user-centered design , spatial data abstraction , and interactive exploration of multivariate datasets. Her work often integrates real-world behavioral data such as GPS tracks, cycling patterns, and crowd-sourced information to build meaningful visual narratives and support analytical reasoning. Throughout her career, Jo Wood has contributed significantly to the advancement of visual analytics through high-impact publications in top-tier venues such as IEEE Transactions on Visualization and Computer Graphics and Computer Graphics Forum. Her collaborations with researchers like Jason Dykes and Aidan Slingsby highlight her role in a vibrant research community. She has supervised numerous research projects and mentored students in visualization and geospatial analytics, though specific names are not listed in the provided text. Her work has been supported by various research grants, particularly in domains involving urban mobility, energy modeling, and crisis informatics, though grant details are not specified here. Jo Wood has also contributed to the design of visual analytics systems for applications including disease spread modeling, bicycle-hire scheme monitoring, and persuasive technology for health and leisure, demonstrating a strong commitment to impactful, interdisciplinary research.
Gene Cooperman is a Professor at the Khoury College of Computer Sciences at Northeastern University, with an affiliation in the College of Engineering. His research focuses on high-performance computing (HPC), transparent checkpoint-restart systems, and model checking. He leads the High Performance Computing Laboratory, where he explores checkpointing technologies like DMTCP, MANA for MPI, and CRAC for CUDA, aiming to enhance HPC workflows on supercomputers such as NERSC's Perlmutter. His work bridges distributed computing, parallel algorithms, and system software to address challenges in fault tolerance, scalability, and resource management. Cooperman has advised 10 PhD students and co-authored over 125 refereed publications, contributing to projects like Geant4-MultiThreaded and Roomy for disk-based computation. His teaching includes courses on computer systems and HPC seminars. Education: Background in computational algebra and parallel computing, transitioning to HPC systems and checkpointing. Research Themes: Transparent checkpointing, MPI agnostic solutions, CUDA integration, and HPC resource optimization. Recent articles emphasize MPI checkpointing, reversible debugging (FReD), and CUDA support, reflecting trends in distributed and GPU-accelerated systems. His grants include NSF, NERSC/DOE, and MemVerge funding. Cooperman collaborates with institutions like CERN and NERSC, advancing applications in particle physics simulations and supercomputing. Current students include Aayushi Gautam, Jiajun Cao, Rohan Garg, and Twinkle Jain.
Yongjoo Park is an Assistant Professor in the Department of Computer Science at the University of Illinois at Urbana-Champaign (UIUC), affiliated with the Grainger College of Engineering. He leads research in data-intensive AI systems as a member of the Data and Information Systems (DAIS) lab, focusing on novel data systems that bridge database theory and practical AI applications. His work emphasizes open-source contributions through GitHub and direct societal impact. Research interests center on systems for data-intensive AI , particularly efficient Retrieval-Augmented Generation (RAG) systems for exploratory AI, data science versioning, and in-storage computing. Key projects include Kishu (the world's first undoable Jupyter notebook with time-travel capabilities), CARE (a causal-relational system for structured/unstructured data), and AirDB/AirIndex (serverless transactions and automatic index optimization). His group develops tools enabling scalable, optimized AI workflows from storage layers to LLM inference. Recent publications reveal a strong focus on interactive data systems (85% of recent work), with significant contributions to notebook environments (Kishu), vector databases (ISCA'25), and RAG optimization. Awards highlight technical innovation, including SIGMOD 2025 Best Demo Award and NSF CAREER funding. His open-source philosophy drives GitHub releases of all major systems. SIGMOD 2025 Best Demo Award (Kishu) NSF CAREER Award (Novel data science systems) SIGMOD'23 Best Artifact Award Honorable Mention (DeepOLA) IBM-Illinois Project Selection (VectorDB/RAG) Mentorship spans 12 current PhD/MS students and 6 graduated advisees, including Supawit Chockchowwat (now Postdoc at Google, future Assistant Professor at CMKL University). He teaches advanced courses like CS511 (Advanced Data Management) and recruits 1-2 new PhD students annually, prioritizing data systems research. His lab emphasizes diversity, individual respect, and concrete outcomes in a collaborative workspace.
Caetano Reis e Sousa is a Professor of Immunology at Imperial College London and Senior Group Leader/Assistant Research Director at the Francis Crick Institute. He leads the Immunobiology Laboratory, focusing on dendritic cell biology, immune responses to pathogens, and cancer immunotherapy. His research explores how dendritic cells detect pathogens and dying cells, triggering adaptive immunity. Key roles include investigating cross-presentation mechanisms, C-type lectin receptors (e.g., DNGR-1), and vaccine development strategies. Education: BSc (Hons) Biology from Imperial College London (1989), DPhil in Immunology from University of Oxford (1992). Postdoctoral training at NIH under Ron Germain. Career milestones include founding the Immunobiology Lab at CRUK London Research Institute (1998–2015) before joining the Crick. Awards & Recognition: Highly Cited Researcher (Thomson Reuters), BD Biosciences Prize (2002), Liliane Bettencourt Award (2008), Louis-Jeantet Prize (2017), Fellowships at Royal Society (2019), Academy of Medical Sciences (2006), and EMBO (2006). Named Officer of the Order of Sant'Iago da Espada (Portugal, 2009). Research Themes: Dendritic cell activation pathways, cross-presentation of tumor antigens, microbiome-cancer immunity links, and immune evasion mechanisms. Collaborations involve institutions like UCL, King's College London, and global health networks. Labs/Teams: Head of Immunobiology Lab at Crick, with expertise in immunology, cell biology, and virology. Facilities include Flow Cytometry, Genomics, and Light Microscopy cores. Active in pandemic response (e.g., SARS-CoV-2 testing initiatives).
Ping Yang is a Professor and Associate Director for Research and Graduate Programs in the School of Computing at Binghamton University (SUNY). She holds a Ph.D. in Computer Science from Stony Brook University, an ME from the Chinese Academy of Sciences, and a BS from Zhongshan University. Her research focuses on cybersecurity, AI-based security, virtual machine security, privacy policy analysis, and formal methods. She directs the Center for Information Assurance and Cybersecurity and coordinates cybersecurity programs at both undergraduate and graduate levels. Education: BS in Computer Science, Zhongshan University ME in Computer Science, Chinese Academy of Sciences MS and PhD in Computer Science, State University of New York at Stony Brook Research Interests: Dr. Yang's work spans information and systems security, security in virtualized computing, access control mechanisms, privacy policies, and formal methods for security verification. Her projects include blockchain-based provenance storage, real-time anomaly detection in workflows, and privacy-preserving virtual machine migration. She has led NSF-funded initiatives on security in cloud environments and scientific workflows. Awards: Not explicitly listed in the provided materials. Advising & Grants: Advised over 30 PhD/Master’s students and contributed to grants including NSF Scholarship for Service and GenCyber programs. Her team develops tools like RBAC-PAT for access control analysis. Labs/Teams: Leads the Center for Information Assurance and Cybersecurity and collaborates on projects involving secure data workflows and blockchain applications in scientific research.
Theresa Raimondo is the Manning Assistant Professor of Engineering at Brown University, with a secondary appointment in the Division of Biology and Medicine. She joined the Brown Engineering faculty in January 2024 after completing her postdoctoral training at MIT's Koch Institute. Dr. Raimondo leads the Raimondo Research Lab, which focuses on chemically modifying RNA and designing nanoparticles for therapeutic delivery to the body, an immunotherapy concept that holds immense promise in the field of immunoengineering. Her educational background includes: PhD in Engineering Sciences – Bioengineering from Harvard University (2019) MEng from Harvard University (2019) Sc.B. in Chemical and Biochemical Engineering from Brown University (2011) Dr. Raimondo's research is broadly focused on the design of targeted drug-delivery vectors and novel RNA-based therapeutics for applications in cancer, immunotherapy, and tissue regeneration. Her work primarily centers on developing novel lipid nanoparticles (LNPs) for RNA-based therapies, contributing to adjuvanted mRNA-based vaccines and siRNA-based cancer immunotherapies. By optimizing LNP formulation and modulating RNA constructs, she seeks to understand how RNA-LNPs modulate immunity and develop new therapeutic approaches. Her expertise spans biomaterials, drug delivery, biomolecular engineering, nanomedicine, tissue engineering, and regenerative medicine. Analysis of Dr. Raimondo's recent publications reveals a strong focus on RNA delivery systems and lipid nanoparticle technology. Her work spans from fundamental studies on nanoparticle design to applications in cancer immunotherapy, vaccine development, and tissue regeneration. A significant portion of her research involves optimizing lipid formulations for improved mRNA delivery and exploring how these systems interact with the immune system. Her publications demonstrate a trajectory from basic biomaterials research to increasingly translational work with therapeutic applications. Dr. Raimondo has received numerous prestigious awards: 2025 NAE Symposium selection (Grainger Foundation Frontiers of Engineering) 2025 appointment to the inaugural Early Career Board of ACS Applied Bio Materials 2024 selection as MIT Faculty Founder Initiative finalist 2022 Convergence Scholar fellowship from MIT's Marble Center for Cancer Nanomedicine National Science Foundation graduate research fellowship Harvard's Smith family graduate fellowship Dr. Raimondo is actively involved in mentoring students through courses including ENGN 0931L - Biomedical Engineering Design and Innovation II, ENGN 1490 - Biomaterials, and ENGN 1931L - Biomedical Engineering Design and Innovation II. Her research program is supported by various grants, though specific funding sources aren't detailed in the provided text. The Raimondo Research Lab represents a dynamic environment where engineering principles are applied to solve complex biological challenges in drug delivery and regenerative medicine. The Raimondo Research Lab at Brown University serves as a hub for innovation in RNA delivery and biomaterials design. The lab brings together expertise in chemical engineering, molecular biology, and immunology to develop next-generation therapeutic platforms. Current research directions include optimizing lipid nanoparticle formulations, exploring novel RNA modifications, and investigating immune responses to RNA therapeutics across various disease contexts.
